AtriCure, Inc. - Common Stock (ATRC)
34.34
+0.25 (0.75%)
NASDAQ · Last Trade: Oct 31st, 10:26 AM EDT
AtriCure (ATRC) Q3 2025 Earnings Call Transcript
Via The Motley Fool · October 30, 2025
AtriCure's Q3 2025 earnings beat expectations with a narrowed loss and strong revenue growth. The medical device firm also raised its full-year financial outlook.
Via Chartmill · October 29, 2025
Via Benzinga · July 30, 2025
Via Benzinga · July 29, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · July 29, 2025
Via Benzinga · April 30, 2025

Via Benzinga · February 10, 2025

Via Benzinga · January 22, 2025

Via Benzinga · January 22, 2025

Via Benzinga · December 9, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 29, 2024

ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 30, 2024
